Study on the efficacy and safety of cephalexin for acute uncomplicated cystitis
- Conditions
- acute uncomplicated cystitis
- Registration Number
- JPRN-UMIN000049903
- Lead Sponsor
- Sapporo Medical University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 300
Not provided
1) Patients who received other antimicrobial agents prior to the start of study drug and whose symptoms are already improving. 2) Patients who have received a cephalosporin antibiotic within 1 week prior to the start of study drug administration 3) Patients with severe infections that are not expected to respond to oral therapy 4) Patients with serious underlying diseases or complications that make it difficult to evaluate the efficacy and safety of the study drug 5) Patients with a history of allergy to cephalosporins 6) Patients with severe cardiac or hepatic dysfunction 7) Patients with moderate or severe renal dysfunction (serum creatinine level should be 2 mg/dL or higher) 8) Patients with epilepsy or other convulsive disorders or a history of such disorders 9) Pregnant women, women who may be pregnant, and lactating women 10) Other patients deemed inappropriate by the attending physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary efficacy from the end of the medication to 10 days after the end of the medication
- Secondary Outcome Measures
Name Time Method Safety